Key facts
- It has raised $28.4M; the latest was Later Stage VC ($11.0M) in Apr 2025.
- Notable investors include Fulcrum Equity Partners, Innovatemap, Mutual Capital Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Olio (Business/Productivity Software)
- ·The full record, as it builds
Funding rounds
No funding rounds for Olio (Business/Productivity Software) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Olio (Business/Productivity Software)
Operator of a digital communication platform designed to connect acute and post-acute providers by surgical specialty. The company's platform provides clear and immediate insights into the patient's condition, improves clinical effectiveness, and offers a dashboard to make accountability and visibility effortless and a playbook to create a shared language for better outcomes, enabling service providers to easily manage their patients, perform in value-based risk arrangements and eliminate unnecessary workflows.
- Sector
- Information Technology
- HQ
- Indianapolis, IN, United States
- Founded
- 2017
- Employees
- 87
- Website
- olio.health/
- Ownership
- Privately Held (backing)
Olio (Business/Productivity Software) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Olio (Business/Productivity Software) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Olio (Business/Productivity Software) in its N-PORT filings yet. We sweep new filings monthly.